{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:23:23Z","timestamp":1765610603089,"version":"build-2065373602"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dextromethorphan (DM) is a cough suppressant that is widely available in many prescribed and over-the-counter medications. Both immediate and delayed hypersensitivity reactions have been reported following the ingestion of DM. Anaphylaxis to DM is rare, with only three reported cases in the literature. Among these, skin prick testing for DM yielded a positive result in one case, a negative result in another, and was not performed in the third.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present a rare case of anaphylaxis linked to DM, confirmed by skin testing. The patient experienced a severe allergic reaction after taking Vicks Dayquil Complete\u00ae, a common over-the-counter cold and flu medicine that contains acetaminophen, DM, phenylephrine hydrochloride, and guaifenesin. Among these, only DM triggered a positive response on skin testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights an uncommon allergy to a combination cold medicine, with skin testing identifying DM as the cause.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-025-00987-y","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:24Z","timestamp":1761901644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anaphylaxis to dextromethorphan with positive skin testing: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Eman","family":"Badawod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"3","key":"987_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2165\/00002018-199207030-00004","volume":"7","author":"JL Bem","year":"1992","unstructured":"Bem JL, Peck R. Dextromethorphan: an overview of safety issues. Drug Saf. 1992;7(3):190\u20139. https:\/\/doi.org\/10.2165\/00002018-199207030-00004.","journal-title":"Drug Saf"},{"key":"987_CR2","doi-asserted-by":"publisher","unstructured":"Dextromethorphan. In: Aronson JK, editor. Meyler's side effects of drugs. 16th ed. Amsterdam: Elsevier; 2016. p. 899\u2013905. https:\/\/doi.org\/10.1016\/B978-0-444-53717-1.00601-6.","DOI":"10.1016\/B978-0-444-53717-1.00601-6"},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.01.016","volume":"159","author":"L Nguyen","year":"2016","unstructured":"Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR. Dextromethorphan: an update on its utility for neurological and neuropsychiatric disorders. Pharmacol Ther. 2016;159:1\u201322. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.01.016.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"987_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s13181-013-0352-5","volume":"9","author":"TJ Wiegand","year":"2013","unstructured":"Wiegand TJ, Wax PM, Smith ER, Hart KM, Brent J. The toxicology investigators consortium case registry\u2014the 2012 experience. J Med Toxicol. 2013;9(4):380\u2013404. https:\/\/doi.org\/10.1007\/s13181-013-0352-5.","journal-title":"J Med Toxicol"},{"issue":"10","key":"987_CR5","first-page":"20030","volume":"19","author":"MM Otero Rivas","year":"2013","unstructured":"Otero Rivas MM, S\u00e1nchez Sambucety P, Garc\u00eda-Ruiz de Morales JM, P\u00e9rez Paredes G, Rodr\u00edguez Prieto MA. Acute generalized exanthematous pustulosis due to dextromethorphan. Dermatol Online J. 2013;19(10):20030.","journal-title":"Dermatol Online J"},{"issue":"2","key":"987_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0091-6749(98)70130-3","volume":"102","author":"SR Knowles","year":"1998","unstructured":"Knowles SR, Weber EA. Dextromethorphan anaphylaxis. J Allergy Clin Immunol. 1998;102(2):316\u20137. https:\/\/doi.org\/10.1016\/S0091-6749(98)70130-3.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"987_CR7","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/j.1398-9995.2004.00565.x","volume":"59","author":"T Robledo","year":"2004","unstructured":"Robledo T, L\u00f3pez-Serrano MC, Mart\u00ednez-Molero MI, Vel\u00e1squez F. Adverse reaction to dextromethorphan. Allergy. 2004;59(8):890. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00565.x.","journal-title":"Allergy"},{"key":"987_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ped.70036","volume":"67","author":"N Kajita","year":"2025","unstructured":"Kajita N, Yoshida K. Anaphylactic shock due to dextromethorphan confirmed by a drug provocation test despite negative SPT and BAT results. Pediatr Int. 2025;67:e70036. https:\/\/doi.org\/10.1111\/ped.70036.","journal-title":"Pediatr Int"},{"key":"987_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109248","volume":"330","author":"T Hu","year":"2020","unstructured":"Hu T, Hou Y, Lu J, Wang X, Wei D, Wang C. Dextromethorphan\u2014a widely used cough suppressant\u2014induces local anaphylaxis via MRGPRX2 on mast cells. Chem Biol Interact. 2020;330:109248. https:\/\/doi.org\/10.1016\/j.cbi.2020.109248.","journal-title":"Chem Biol Interact"},{"issue":"3","key":"987_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jcp.2004.017210.PMID:15735162;PMCID:PMC1770584","volume":"58","author":"AS Janssens","year":"2005","unstructured":"Janssens AS, Heide R, den Hollander JC, Mulder PG, Tank B, Oranje AP. Mast cell distribution in normal adult skin. J Clin Pathol. 2005;58(3):285\u20139. https:\/\/doi.org\/10.1136\/jcp.2004.017210.PMID:15735162;PMCID:PMC1770584.","journal-title":"J Clin Pathol"},{"issue":"6","key":"987_CR11","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jaci.2016.02.015","volume":"137","author":"FD Finkelman","year":"2016","unstructured":"Finkelman FD, Khodoun MV, Strait RT. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol. 2016;137(6):1674\u201380. https:\/\/doi.org\/10.1016\/j.jaci.2016.02.015.","journal-title":"J Allergy Clin Immunol"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00204-022-03402-2","volume":"97","author":"BA Baldo","year":"2023","unstructured":"Baldo BA, Pham NH. Opioid toxicity: histamine, hypersensitivity, and MRGPRX2. Arch Toxicol. 2023;97:359\u201375. https:\/\/doi.org\/10.1007\/s00204-022-03402-2.","journal-title":"Arch Toxicol"},{"key":"987_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676354","volume":"12","author":"BD McNeil","year":"2021","unstructured":"McNeil BD. MRGPRX2 and adverse drug reactions. Front Immunol. 2021;12:676354. https:\/\/doi.org\/10.3389\/fimmu.2021.676354.","journal-title":"Front Immunol"},{"issue":"4","key":"987_CR14","first-page":"281","volume":"23","author":"G Davila-Fern\u00e1ndez","year":"2013","unstructured":"Davila-Fern\u00e1ndez G, V\u00e1zquez-Cort\u00e9s S, Moreno-De Vega MJ, Chamorro-G\u00f3mez M, Elices-Apell\u00e1niz A. Fixed drug eruption due to dextromethorphan with tolerance to other opioids. J Investig Allergol Clin Immunol. 2013;23(4):281\u20132.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"987_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.iac.2009.04.002","volume":"29","author":"E Florvaag","year":"2009","unstructured":"Florvaag E, Johansson SG. The pholcodine story. Immunol Allergy Clin North Am. 2009;29(3):419\u201327.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9S","key":"987_CR16","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","volume":"8","author":"AD Broyles","year":"2020","unstructured":"Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, et al. Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract. 2020;8(9S):S16\u2013116. https:\/\/doi.org\/10.1016\/j.jaip.2020.08.006.","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00987-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-025-00987-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00987-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:26Z","timestamp":1761901646000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-025-00987-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1186\/s13223-025-00987-y","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}